171 related articles for article (PubMed ID: 35388751)
1. ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Comb Chem High Throughput Screen; 2023; 26(1):135-148. PubMed ID: 35388751
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
[TBL] [Abstract][Full Text] [Related]
3. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning.
Ji Y; Lin Z; Li G; Tian X; Wu Y; Wan J; Liu T; Xu M
Front Genet; 2023; 14():1136783. PubMed ID: 37732314
[No Abstract] [Full Text] [Related]
5. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
6. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
7. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
Gong Y; Wei ZR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
[TBL] [Abstract][Full Text] [Related]
8. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy.
Niu J; Yan T; Guo W; Wang W; Zhao Z; Ren T; Huang Y; Zhang H; Yu Y; Liang X
Front Oncol; 2020; 10():1628. PubMed ID: 32974202
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
13. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma.
Hu D; Zheng Y; Ou X; Zhang L; Du X; Shi S
Front Oncol; 2022; 12():973914. PubMed ID: 36003792
[TBL] [Abstract][Full Text] [Related]
15. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
16. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes in osteosarcoma - before and after CDK7 treatment.
An Y; Wang Y; Xu G; Liao Y; Huang G; Jin X; Xie C; Li Q; Yin D
Medicine (Baltimore); 2021 Oct; 100(39):e27304. PubMed ID: 34596127
[TBL] [Abstract][Full Text] [Related]
18. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
20. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.
Chen G; Wang Q; Yang Q; Li Z; Du Z; Ren M; Zhao H; Song Y; Zhang G
PLoS One; 2018; 13(8):e0202896. PubMed ID: 30153287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]